JP1689512S - - Google Patents
Info
- Publication number
- JP1689512S JP1689512S JPD2020-26927F JP2020026927F JP1689512S JP 1689512 S JP1689512 S JP 1689512S JP 2020026927 F JP2020026927 F JP 2020026927F JP 1689512 S JP1689512 S JP 1689512S
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPD2020-26927F JP1689512S (Direct) | 2020-12-15 | 2020-12-15 | |
| US29/777,239 USD991180S1 (en) | 2020-12-15 | 2021-04-05 | Connector |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPD2020-26927F JP1689512S (Direct) | 2020-12-15 | 2020-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP1689512S true JP1689512S (Direct) | 2021-07-12 |
Family
ID=76754312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JPD2020-26927F Active JP1689512S (Direct) | 2020-12-15 | 2020-12-15 |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | USD991180S1 (Direct) |
| JP (1) | JP1689512S (Direct) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD984382S1 (en) * | 2019-05-09 | 2023-04-25 | Ideal Industries, Inc. | Electrical connector |
| USD975025S1 (en) * | 2021-01-13 | 2023-01-10 | J.S.T. Corporation | Connector |
| JP1698589S (Direct) * | 2021-04-19 | 2021-11-01 | ||
| JP1703927S (Direct) * | 2021-06-23 | 2022-01-04 | ||
| JP1728793S (ja) * | 2022-03-04 | 2022-11-01 | コネクタハウジング |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD272144S (en) * | 1980-02-02 | 1984-01-10 | Tokai Electric Wire Co., Ltd. | Connector housing |
| USD315331S (en) * | 1987-12-22 | 1991-03-12 | Yazaki Corporation | Housing for an electrical connector |
| USD314756S (en) * | 1988-04-08 | 1991-02-19 | Yazaki Corporation | Housing for an electrical connector |
| USD314753S (en) * | 1988-04-08 | 1991-02-19 | Yazaki Corporation | Housing for an electrical connector |
| USD324203S (en) * | 1989-06-22 | 1992-02-25 | Yazaki Corporation | Electrical connector housing |
| USD325372S (en) * | 1989-07-07 | 1992-04-14 | Yazaki Corporation | Electrical connector housing |
| USD325563S (en) * | 1989-07-07 | 1992-04-21 | Yazaki Corporation | Electrical connector housing |
| JP2500243Y2 (ja) * | 1991-03-14 | 1996-06-05 | 矢崎総業株式会社 | コネクタ |
| USD523399S1 (en) * | 2004-07-12 | 2006-06-20 | Tyco Electronics Amp K.K. | Connector housing |
| USD564452S1 (en) * | 2005-06-17 | 2008-03-18 | Tyco Electronics Amp Kk | Electrical connector housing |
| JP1584297S (Direct) * | 2017-02-13 | 2017-08-21 | ||
| JP1597118S (Direct) * | 2017-07-07 | 2018-02-13 | ||
| JP1596272S (Direct) * | 2017-08-22 | 2018-01-29 | ||
| JP1609829S (Direct) * | 2017-12-18 | 2018-07-23 | ||
| JP6754392B2 (ja) * | 2018-05-23 | 2020-09-09 | 矢崎総業株式会社 | コネクタ |
| JP1622388S (Direct) * | 2018-08-03 | 2019-01-21 | ||
| JP1669106S (Direct) * | 2020-05-22 | 2020-09-28 | ||
| JP1678785S (Direct) * | 2020-06-01 | 2021-02-08 | ||
| JP1678786S (Direct) * | 2020-06-01 | 2021-02-08 | ||
| JP1678809S (Direct) * | 2020-07-07 | 2021-02-08 | ||
| JP1678808S (Direct) * | 2020-07-07 | 2021-02-08 | ||
| JP1689554S (Direct) * | 2020-12-15 | 2021-07-12 |
-
2020
- 2020-12-15 JP JPD2020-26927F patent/JP1689512S/ja active Active
-
2021
- 2021-04-05 US US29/777,239 patent/USD991180S1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| USD991180S1 (en) | 2023-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR102021007058A2 (Direct) | ||
| BR102020022030A2 (Direct) | ||
| AR134288A1 (es) | UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b | |
| AR134282A1 (es) | Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf | |
| AR134271A1 (es) | Variantes de cnp, conjugados y formulaciones de los mismos | |
| AR134276A1 (es) | ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS | |
| AR134275A1 (es) | Anticuerpos cd24 | |
| AR134266A1 (es) | Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1 | |
| AR134264A1 (es) | Correctores farmacológicos de rodopsina y sus usos | |
| AR134263A1 (es) | Tratamiento de covid persistente con composición de vesículas extracelulares | |
| AR134262A1 (es) | Formulación líquida de agente biológico en almacenamiento estable | |
| AR134259A1 (es) | Compuestos de pirimidina bicíclicos, métodos y usos de estos | |
| AR134258A1 (es) | Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina | |
| AR134257A1 (es) | Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina | |
| AR134219A1 (es) | Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos | |
| AR134214A1 (es) | Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central | |
| AR134215A1 (es) | Compuestos de tiazol y métodos de uso | |
| AR134203A1 (es) | Compuestos para la degradación de braf mutante | |
| AR134206A1 (es) | Degradantes y usos de los mismos | |
| AR134200A1 (es) | Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales | |
| AR134198A1 (es) | Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1) | |
| AR134193A1 (es) | Métodos para tratar tumores tenosinoviales de células gigantes | |
| AR134194A1 (es) | Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos | |
| AR134185A1 (es) | Anticuerpos anti-receptor de transferrina y usos de estos | |
| AR134180A1 (es) | Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos |